NCT03875989

Brief Summary

The aim of the study is to assess at one year the effectiveness of the vaginal patch plastron in comparison of the anterior colporraphy through a combined definition of success: anatomic and functional.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
214

participants targeted

Target at P75+ for not_applicable

Timeline
23mo left

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

9 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Sep 2019Mar 2028

First Submitted

Initial submission to the registry

March 13, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 15, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

September 27, 2019

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 27, 2025

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 27, 2028

Expected
Last Updated

August 29, 2023

Status Verified

August 1, 2023

Enrollment Period

6 years

First QC Date

March 13, 2019

Last Update Submit

August 28, 2023

Conditions

Keywords

ProlapseVaginal native tissues repairPelvic organ

Outcome Measures

Primary Outcomes (1)

  • Rate of the prolapse surgery

    The success rate of the prolapse surgery defined by a composite of objective and subjective measures: * Anatomic success defined by Aa and Ba values \<0 in Pelvic Organ Prolapse Quantification System (POP-Q) AND * Subjective success through reliable condition-specific quality-of-life questionnaires: * A negative response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the Pelvic Floor Distress Inventory (PFDI-20)) AND * Range score of Patient Global Impression of Improvement (PGI-I) 1 or 2 AND * No need for other treatment for prolapse (surgical nor medical)

    1 year

Secondary Outcomes (5)

  • Rate of the prolapse surgery

    1 year

  • Rate of post-operative complications

    45 Days

  • Sexual function

    1 year

  • Rate of the prolapse surgery

    2 years

  • Rate of the prolapse surgery

    3 years

Study Arms (2)

Arm A

ACTIVE COMPARATOR
Procedure: Anterior colporraphy

Arm B

EXPERIMENTAL
Procedure: vaginal patch plastron

Interventions

It will be delimitate a rectangular vaginal strip which will be isolated from the anterior colpocele. The superior edge of the strip is placed 2 cm from the urethral orifice. After lateral vesico-vaginal dissection, the paravesical fossae will be wide opened to repair the tendinous arches. The vaginal plastron will be fixed to the tendinous arch of the pelvic fascia by 3 lateral stitches (anterior/ lateral/ posterior) on each side of the plastron. After, the plastron will be tensioning and the cystocele will be suspended. The closure of the vaginal wall will end the procedure.

Arm A

It will be make a midline incision of the anterior vaginal wall from the urethrovesical junction to the vaginal apex or anterior fornix. The vaginal epithelium will be separated from the underlying fibromuscular layer (Halban Fascia) after the midline incision. Midline plication of the fibromuscular layer will be obtained by interrupted horizontal stiches. The closure of the vaginal wall will end the procedure.

Arm B

Eligibility Criteria

Age50 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient at 50 years of age or older
  • Symptomatic primary prolapse of the anterior vaginal wall defined by Aa and/or Ba points ≥0 according to the POP-Q system
  • A positive response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the PFDI-20)
  • Able to give informed consent
  • Performans Status score ≤ 2

You may not qualify if:

  • Patient with need for surgical treatment for myorraphy of levator ani muscles
  • Patient with previous surgical cystocele repair.
  • Patient with evolving gynaecologic cancer.
  • Pregnancy or wish for future pregnancy, lactating woman.
  • Inability to participate in study follow-up or to provide informed consent.
  • Lack of social insurance .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

CHU de Bordeaux

Bordeaux, 33000, France

RECRUITING

CH de Brive

Brive-la-Gaillarde, 19100, France

RECRUITING

CHU de Clermont Ferrand

Clermont-Ferrand, 63100, France

RECRUITING

CH de Gueret

Guéret, 23000, France

RECRUITING

CHU de Limoges

Limoges, 87000, France

RECRUITING

CHU de Saint-Etienne

Saint-Etienne, 42000, France

RECRUITING

CHU de Toulouse - Paule de Viguier

Toulouse, 31059, France

RECRUITING

CHU de Toulouse - Rangueil

Toulouse, 31400, France

RECRUITING

CH de Tulle

Tulle, 19000, France

RECRUITING

Related Publications (1)

  • Lacorre A, Vidal F, Campagne-Loiseau S, Marin B, Aubard Y, Siegerth F, Mesnard C, Chantalat E, Hocke C, Gauthier T. Protocol for a randomized controlled trial to assess two procedures of vaginal native tissue repair for pelvic organ prolapse at the time of the questioning on vaginal prosthesis: the TAPP trial. Trials. 2020 Jul 8;21(1):624. doi: 10.1186/s13063-020-04512-x.

MeSH Terms

Conditions

Uterine ProlapseProlapse

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPelvic Organ ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental, parallel-group randomised controlled trial (1:1), multicentric. The primary outcome and the secondary outcome 1 and 3 will be evaluated in double blind; only the secondary outcome 2 will not be evaluated in blind.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2019

First Posted

March 15, 2019

Study Start

September 27, 2019

Primary Completion

September 27, 2025

Study Completion (Estimated)

March 27, 2028

Last Updated

August 29, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations